Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations

PURPOSE: Platinum-based doublet chemotherapy is the treatment of choice for patients with non-small cell lung cancer (NSCLC); however, the role of a platinum-based doublet as second-line therapy after failure of an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) for NSCLC pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sehhoon, Keam, Bhumsuk, Kim, Se Hyun, Kim, Ki Hwan, Kim, Yu Jung, Kim, Jin-Soo, Kim, Tae Min, Lee, Se-Hoon, Kim, Dong-Wan, Lee, Jong Seok, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614214/
https://www.ncbi.nlm.nih.gov/pubmed/25687850
http://dx.doi.org/10.4143/crt.2014.244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614214/
https://www.ncbi.nlm.nih.gov/pubmed/25687850
http://dx.doi.org/10.4143/crt.2014.244

Ejemplares similares